Older adults schedule point

Individuals are given two vaccinations at the older adults National Immunisation Program schedule point:

• Prevenar 13 protects against pneumococcal disease
• Shingrix® protects against shingles

AusVaxSafety has been conducting surveillance of the vaccines given at the older adults schedule point on a continuous basis since 2019. The analysis has remained constant over this time and not identified any safety concerns.

The latest medical attendance rate for the older adults schedule point is below and will be updated on a quarterly basis.

In April 2022, the vaccine safety survey used for active surveillance of vaccines on the National Immunisation Program was updated to replicate the vaccine safety survey used for COVID-19 and seasonal influenza vaccine surveillance to allow for better comparison across all vaccines monitored. Data displayed on this page show analysis of the new survey. Reassuringly, data from the new vaccine safety survey are comparable to the rates reported in the previous survey.

More detailed safety data from the older adults schedule point is available from the 2022 Vaccine Safety in Australia AusVaxSafety Summary Report below.

Access AusVaxSafety data from the older adults schedule point for 2022